🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Dr. Arjun Sahgal and the team at Sunnybrook Health Sciences Centre have been working on a trial exploring radiosurgery for treating up to 50 brain mets. Hear how he's worked to challenge the way multiple brain metastases are treated and why whole brain radiation should be considered only as a last

It was an honor to receive from my friend, and health care advocate, MP Sonia Sidhu the Coronation Medal of King Charles III. The global impact in neurooncology for CNS tumours, we continue to achieve Sunnybrook Health Sciences Centre, reflects the entire team's dedication to our cancer patients. 🙏

Congrats Katarzyna Jerzak, our Sunnybrook Health Sciences Centre breast cancer medical oncolgist, continues to interrogate associations and novel therapeutics for her2+ve disease. Check out the latest paper as we continue to learn about her2 low status and brain metastases. pubmed.ncbi.nlm.nih.gov/40048670/

Is MR-Linac a better choice in Adaptive Radiotherapy when compared with CT-basedRT? #adaptiveradiotherapy #radoncs #MRlinac #radiotherapy Read here our written crossfire debate on this emerging topic on medicalphysics 👉pubmed.ncbi.nlm.nih.gov/40056130/

The #RTi3Conference is almost here! Our program schedule and speaker lineup is NOW LIVE. Don’t miss out! 🎟️Secure your spot by March 13 (11:59 PM EDT): bit.ly/3Ow2VPF 🗓️View full program schdeule: uoft.me/rti3-2025-sche…

Eight Sunnybrook physicians have been awarded a King Charles III Coronation Medal for their contributions to healthcare in Canada! Their dedication and commitment to patients are why #ThisPlaceIsSpecial. Learn more about their incredible work: bit.ly/4jgFEhR

Research program still going strong as ever under his amazing leadership. He just sees less patients so has more time at home which I am sure the clinic organizers are relieved about, but perhaps not his wife

We're hiring! Clinical Oncology Research Fellow opportunity at The Royal Marsden NHS Foundation Trust The ICR to work on the landmark PACE trial & future prostate radiotherapy studies. Work with me, Prof Emma Hall Yae-eun Suh Join us! #OncologyJobs royalmarsden.nhs.uk/current-vacanc… Alison Tree 💙 Clive Peedell

Dr. arjun sahgal and the Sunnybrook Health Sciences Centre team are leading the charge in the first adaptive MRgRT study, the UNITED trial, for patients with high-grade gliomas, the most common and aggressive primary brain tumors in adults. Learn more in episode 2 of Spilling the RT

Wee Loon Ong leads pub in European Urology Oncology for #PATRIOT (#SBRT weekly vs every other day treatment for favourable risk #prostatecancer ) No stat diff in bioc fail (mFU of 91mo) Planning to combine with Thomas Zilli #NOVALIS study (same design) free link👉tinyurl.com/yyhd69c2

Every Other Day or Once a Week: Long-term Oncological Outcomes in the Phase 2 PATRIOT Trial of Prostate Stereotacti… pubmed.ncbi.nlm.nih.gov/40288917/

Danny Vesprini Rubén Del Castillo Piet Ost Paul Sargos Alison Tree 💙 Pierre Blanchard, MD Vérane Achard Vedang Murthy and many many more on X! Special thx to Constantinos Zamboglou organizing this epic event!

Active Surveillance for Favorable intermediate risk prostate cancer. Safe option for select patients. Data presented on #ESTRO25 Dr. Andrew Loblaw Danny Vesprini

It was a privilege to be a part of this guideline. Great that we have clear guidance to improve patient outcomes.

Congratulations to Dr. DeepakDinakaran on receiving the Hold’em for Life Early Career Professorship in Cancer Research at University of Toronto. His innovative work in radiation-activated photodynamic therapy (radioPDT) is advancing the future of precision radiation oncology.

The HERMES trial from RMH London studied two MRI-guided adaptive prostate radiotherapy regimens. It found that both 5 and 2 fraction treatments are feasible with encouraging toxicity outcomes. redjournal.org/article/S0360-… Prostate Cancer UK Prostate Cancer Foundation #ProgressThroughCollaboration

I think for intermediate risk, the DESTINATION2 concept will be the future (de-escalated dose and 0mm PTV margin). Why? Because we already have 99% freedom from Mets at 15y with “classic” SBRT. pubmed.ncbi.nlm.nih.gov/39293531/ Now focus should be on even better QOL

Congratulations Dr Gerard Morton on this well deserved recognition- 2025 Henschke Award recipient. We cannot be more proud of our Canadian Brachytherapy leaders @mirakeyes ⁦CBG⁩ ⁦Radiation Oncology⁩

Thrilled to complete my first year of fellowship! 🙌 Immense gratitude to all my mentors, especially Dr. Andrew Loblaw for shaping me into a better RadOnc. Honored to meet future RadOnc stars! 🌟

We’re excited to kick off a new chapter this academic year by welcoming our five Radiation Oncology #PGY1 residents - Victoria, Sagar Grewal , Caroline, Moudhi, and Melissa Sam Soon! So happy to have you join the UTDRO family! Andrea Bezjak Learn more: uoft.me/utdro-PGY1-2025